Special Lecture 1 : The finding, development and progress of potassium channel openers
著者 柳澤 輝行
The finding, development and progress of
potassium channel openers.
Teruyuki YANAGISAWA, MD, PhD
Dept. Mol. Pharmacol.,
Tohoku Univ. Sch. Grad. Med.
The 87
thAnnual Meeting of The
Japanese Pharmacological Society
Sendai, 20140319, 10:45-11:45
☑
The author has no conflict of interest
to disclose with respect to this
The development of nicorandil (SG-75)
The development of nicorandil (SG-75) was started under
the concept “a nitrate-like antianginal drug without
hypotensive side effect”. During the studies to explore the
mechanism of action of nicorandil, it has been revealed that
nicorandil opens potassium (K
+) channel and that
ATP-sensitive K
+channels (K
ATP
) are the target molecules, which
are also opened by other K
+channel openers (KCO) as
antihypertensives. Although the clinical results related with
pure KCOs for hypertension have been failed, nicorandil
which is a hybrid of nitrate and KCO has been successful as a
drug for angina pectoris, acute myocardial infarction and
acute heart failure. We have also suggested that nicorandil
will be effective in managing pulmonary arterial
hypertension. The KCOs targeting other than K
ATPare
expected to be novel therapeutic agents to control pain or
epilepsy, including many pathological situations.
K
+
channel openers (K
ATP
COs)
•
Historical points of view
•
Why they are not successful for the
antihypertensive agents?
•
Vasospastic angina
•
Hyperpolarization-relaxation coupling
•
Progress of new types KCOs
minoxidil, LP 805 Pyrimidine: O N N N H 2 H2N N trichogen Benzopyran: Cromakalim O H N C O C H 3 C H 3 N O * *
K
+
channel openers
Pyridine:nicorandil
KRN2391 C O N H C H 2C H 2O N O 2 N "N-K hybrid" NO, cGMP ↑ Hyperglycemia (side effect) Insulin secretion↓ KATP open in β cell3 N NH S O Cl CH 2 Benzothiadiazine: diazoxide "Nonspecific KCO" Hypertricosis as a side effect
cf. ischemic preconditioning;
pharmacological
The development of nicorandil (SG-75)
•
Blood-perfused cardiac preparations in
Tohoku University
•
The serendipity to find K
+opening activity
Dr. Sakai, K
(Born in Ishinomaki)
The Development of nicorandil
Blood
pressure
(mmHg)
Coronary
blood flow
(ml/min)
Heart rate
(beats/min)Nicorandil
Modified from i. v.: intravenous injectionNicorandil
(SG-75):
coronary resistance↓
Intraduodenal administration of nicorandil (3mg/kg) ≒ intravenous injection (0.3mg/kg)
Taira N, Satoh K, Yanagisawa T et al. Clin Exp Pharmacol Physiol 1979;6:301-16. SEM in parentheses, n=5. : P<0.05,
Nicorandil
(SG-75):
coronary resistance↓
Intraduodenal administration of nicorandil (3mg/kg)≒ intravenous injection (0.3mg/kg)
Taira N, Satoh K, Yanagisawa T et al. Clin Exp Pharmacol Physiol 1979;6:301-16. SEM in parentheses, n=5. : P<0.05,
a.v.: arterio-venous; AV: atrioventricular
Distribution of cardiac output & O
2consumption
in organs at rest
Organs Blood flow (mL/min) O2 consumption
(/100g) (Whole) (%) Brain Heart Liver Kidney Sk. muscle Skin Others Total (mL/min) (%)
In heart, the tissue O
2partition pressure is low,
thus the organ is under relatively hypoxic condition.
K
ATPchannels are seemed to be easily opened in heart.
Isolated blood-perfused cardiac preparations
Increase in coronary blood flow,
Very llittle effect on sinoatrial (SA) rate
RA
RV
IVC
SVC SA node
Constant perfusion pressure
Injection, i. a.
SG-75
Nicorandil
Conduction system
AV node
; PSA: posterior septal artery←circumflexus arteryVentricle
; ASA: anterior septal artery←left coronary arterySA node AV node Bundle branch His B. Purkinje f. Slow response Ca2+ channel
Vent. Septum
N-Sch. Arch. Pharmacol. 1975:290:107-12.
Nifedipine vs. nicorandil on AV conduction time
No effect on AV conduction, furthermore
Arterial blood
Extra. potential
Force of contraction
Blood-perfused papillary muscle Fc Extra. potential NicorandilNicorandil 1mg, i.a.
Acute ischemia causes a so-called
current of injury????
The concept of
K
ATP
channel opening
in ischemic/hypoxic cells.
The effect of on APD of cardiac muscle.
(
Ischemia-induced arrhythmia)
(Intra-arterial nicorandil-induced V.F.)
Acute ischemia causes a current of injury
Effort angina predominant subendocardial ischemiaischemia involving the outer ventricular layer (transmural or epicardial injury)
Lead V4
at rest
(top) and after 4.5 min ofexercise
(bottom).There is 0.3 mV of
horizontal ST-segment depression
,
indicating a positive test for ischemia.
1 mV 1 sec P Q R S T
Electrode
Acute ischemia causes ST changes
KATP opened Subendocardium
Epicardium
Conduction
http://ir.library.tohoku.ac.jp/re/bitstream/10097/40205/1/ YANAGISAWA-Teruyuki-01-09-0012.pdf
Ischemic arrhythmias in the light of K
ATPReentry
→VT, VF
SG-75-induced VT & VF in experiments with
blood-perfused canine preparations
We have given clinicians the caution of the risk of
intracoronary administration of nicorandil.
Fortunately, there has been no report related
accidents
(Am J Cardiol 1989;63:18J-24J)
・
Cromakalim and pinacidil, nonnitrate KCO, have
essentially the same cardiovascular profile as nicorandil in
isolated, blood-perfused canine heart preparations.
1) The property of nicorandil as a resistive vessel dilator highly
selective for vasculature originates in its mechanism of action as a K-channel activator.
2) The non-unanimous effect of nicorandil on venous return is a result of the opposing actions as a capacitive (action as a nitrate) and a
resistive vessel dilator.
3) Nicorandil, with its hybrid nature, is advantageous over specific K-channel activators and classic nitrates in therapeutic implications.
Selectivity spectra for coronary blood flow vs. cardiac variables
Am J Cardiol. 1987;59(3):24B-29B
Canine atrial muscle comparison with ACh
Canine atrial muscle comparison with ACh
SG-75 increases P
K
Effect of SG-75 on membrane potentials of a
spontaneously firing canine Purkinje fiber
10
-6M SG-75
10
-5M SG-75
10
-4M SG-75
Control
Slow response in 27 mM K
+20 msec
20 mV
Hyperpolarization
Shorten APD
【Conclusion-1】
Findings in blood-perfused cardiac prep.
•
SG-75 increases coronary blood flow.
•
No effect on AV conduction
•
Induction of ventricular fibrillation in high dose
•
Shorten QT interval
•
Shorten APD of ventricular muscle
The mechanism is not Ca
2+channel blockade.
K
+
channel openers (K
ATP
COs)
•
Historical points of view
•
Why they are not successful for the
antihypertensive agents?
•
Vasospastic angina
•
Hyperpolarization-relaxation coupling
•
Progress of new types KCOs
Treatment of
vasospastic angina
Vm(mV) -55 -90 K+ channel Ca2+ channel Vascular sm.m.tone Vascular diameter K+ channel opener hyperpolarization -75 -40 rested Ca2+ depolarization K+ open Hyperpolarization-relaxation coupling K+ K+ K + K+ K+ Ca2+ Ca2+Ca2+Ca2+ Ca2+ close close open
Hypertension, spasm, agonists
Dissociation of
[Ca
2+]
i
& Force of contraction
Repolarization
vs.
Inhibition of Ca influx
-10mV
-34mV -47mV-55mV
-42mV -38mV -24mV -30mV[Ca
2+
]
i
-Fc relation;
Vm
Repolarization & Ca sensitivity
Membrane potential (mV)
C
hange
s i
n
C
a
sens
iti
vi
ty
(%
)
90K-2.5Ca 5K-2.5CaRhoK distribution
Relationship
between [Ca
2+]
iand force of
contraction
induced by
serotonin ( 10
-6.5M) in the absence
(
○
) and presence
of levcromakalim
( 10
-5.5M,
●
) or
nicardipine (
■).
-60 -40 -20 0 20 40 60 80 0 10 20 30 40 50 60 70 80 90[Ca
2+]
i(%)
c
-10 100F
o
rce (
%)
0 0.1 0.3 1.0 2.5 10 0 0.1 0.3 1.0 2.5 10 *** 10-6.5 M 10-5.5 MCa sensitivity
↓
by a KCO
C
o n t r o l
F
u r a - 2
r
a t i o
0
. 6
0
. 5
F
o r c e
(
m N )
0
3
1 0 m i nU
4 6 6 1 9
C
a f f e i n e
C
r
o
m
a
k
a
l
i
m
1
0
-5M
0
C a
Naunyn-Schmied. Arch. Pharmacol. 1992;346:691-700. Biochem. Biophys. Res. Commun. 1992;187:1517-22. K+ channel opener inhibits IP
3 generation & Ca2+ release from SR by
Activation of phospholipase C by the agonist U46619 is inhibited by cromakalim-induced hyperpolarization in porcine coronary artery. (in the absence of [Ca2+]
o)
Hyperpolarization
Molecular signal mechanisms of
relaxation
of
vascular smooth muscle via Hyperpolarization
Hyperpolarization
Hyperpolarization
Hyperpolarization
K
ATP
K
ca
K
ir
Nicorandil, Nitroglycerin
↓
NO→cGMP→G kinase
Hyperpolarization decreases Ca sensitivity
Hyperpolarization Hyperpolarization
K
ATP
K
ca
K
ir
KCO
Nicorandil
Nitroglycerin
EDHF
Circulation 2011;124:1774-82 (modified)as NK hybrid
In the presence of nitroglycerin,
Dissociation of
[Ca
2+]
i& Fc
Ca
2+
desensitization
Yanagisawa T. Br J Pharmacol 1989; 98: 469Ca
2+
sensitization
Pathogenic mechanisms in coronary artery spasm.
Circulation 2011;124:1774-82
Hyperpolarization:
【Conclusion-2】
Coronary artery spasm mechanisms.
Ca
2+sensitivity in vasc. sm. m. is
increased
or
decreased
by
depolarization
or
hyperpolarization
,
respectively.
The concept of hyperpolarization-relaxation
coupling via. KCO or EDHF is very important,
since we have precisely known the molecular
mechanisms of vasospasm.
K
+
channel openers (K
ATP
COs)
•
Historical points of view
•
Why they are not successful for the
antihypertensive agents?
•
Vasospastic angina
•
Hyperpolarization-relaxation coupling
【Appendix】
The future of K
ATP
COs & other type of KCOs
•
Organ perfusion preservation of organ transplant
•
Pulmonary arterial hypertension; Sahara M et al.
PLoS One. 2012;7(3):e33367. doi: 10.1371/
journal.pone.0033367.
•
Advanced diabetic nephropathy; Tanabe K et al.
Am J Physiol Renal Physiol. 2012;302:F1151-60.
KATP BKCa, IKCa Kv ~100 pS, ~10 pS ~10 pS ~100 pS, ~60 pS -90 -80 -70 -60 -50
Vm
(mV)
100 80 60 40 20 0 150 pS 10 pS 20 pS 40 pS 60 pS 100 pSSingle channel conductance
Open channel number in vascular sm. m. cell E K =
Folia Pharmacol. Jpn. 1995;106:157-69.